Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315620512> ?p ?o ?g. }
- W4315620512 abstract "Alzheimer's disease (AD) is a progressive neurodegenerative brain disease. Thus, drugs including donepezil, rivastigmine, and galantamine are not entirely effective in the treatment of this multifactorial disease. The present study evaluates eight derivatives (3a-3h) as candidates with stronger anti-AD potential but with less side effects. Reactive oxygen species (ROS) assays were used to assess oxidative stress which involve in the neurodegeneration. The neuroprotective properties of 3e against oxidative stress were done in three experiments using MTT test. The anti-AD potential was determined based on their anticholinesterase inhibition ability, determined using Ellman's method, Aβ aggregation potential according to thioflavin (Th) fluorescence assay, and their antioxidative and anti-inflammatory activities. Compound 3e exhibited moderate cholinesterase inhibition activity (AChE, IC50 = 0.131 µM; BuChE, IC50 = 0.116 µM; SI = 1.13), significant inhibition of Aβ(1-42) aggregation (55.7%, at 5 µM) and acceptable neuroprotective activity. Extensive analysis of in vitro and in vivo assays indicates that new cyclopentaquinoline derivatives offer promise as candidates for new anti-AD drugs." @default.
- W4315620512 created "2023-01-12" @default.
- W4315620512 creator A5001142695 @default.
- W4315620512 creator A5004907899 @default.
- W4315620512 creator A5014679299 @default.
- W4315620512 creator A5017302012 @default.
- W4315620512 creator A5024633360 @default.
- W4315620512 creator A5026614694 @default.
- W4315620512 creator A5029691584 @default.
- W4315620512 creator A5031559351 @default.
- W4315620512 creator A5032152156 @default.
- W4315620512 creator A5051025265 @default.
- W4315620512 creator A5069693901 @default.
- W4315620512 creator A5079455118 @default.
- W4315620512 creator A5086573420 @default.
- W4315620512 creator A5086957954 @default.
- W4315620512 date "2023-01-11" @default.
- W4315620512 modified "2023-10-15" @default.
- W4315620512 title "New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease" @default.
- W4315620512 cites W1021164303 @default.
- W4315620512 cites W11695377 @default.
- W4315620512 cites W1524710988 @default.
- W4315620512 cites W1577841378 @default.
- W4315620512 cites W1766611571 @default.
- W4315620512 cites W1970865922 @default.
- W4315620512 cites W1971048984 @default.
- W4315620512 cites W1975040221 @default.
- W4315620512 cites W1981433258 @default.
- W4315620512 cites W1985425337 @default.
- W4315620512 cites W2005614541 @default.
- W4315620512 cites W2005976191 @default.
- W4315620512 cites W2006152123 @default.
- W4315620512 cites W2009033812 @default.
- W4315620512 cites W2009904849 @default.
- W4315620512 cites W2013250854 @default.
- W4315620512 cites W2016991826 @default.
- W4315620512 cites W2017013108 @default.
- W4315620512 cites W2022019019 @default.
- W4315620512 cites W2022387872 @default.
- W4315620512 cites W2028121694 @default.
- W4315620512 cites W2029122074 @default.
- W4315620512 cites W2029436922 @default.
- W4315620512 cites W2038970266 @default.
- W4315620512 cites W2040676526 @default.
- W4315620512 cites W2049192526 @default.
- W4315620512 cites W2050305509 @default.
- W4315620512 cites W2051966430 @default.
- W4315620512 cites W2062159889 @default.
- W4315620512 cites W2063547861 @default.
- W4315620512 cites W2070448139 @default.
- W4315620512 cites W2079609596 @default.
- W4315620512 cites W2089513574 @default.
- W4315620512 cites W2104156437 @default.
- W4315620512 cites W2117685145 @default.
- W4315620512 cites W2121902398 @default.
- W4315620512 cites W2125882717 @default.
- W4315620512 cites W2125985978 @default.
- W4315620512 cites W2141262291 @default.
- W4315620512 cites W2141789505 @default.
- W4315620512 cites W2295659039 @default.
- W4315620512 cites W2302829883 @default.
- W4315620512 cites W2324358173 @default.
- W4315620512 cites W2414355992 @default.
- W4315620512 cites W2538624834 @default.
- W4315620512 cites W2580247531 @default.
- W4315620512 cites W2580292466 @default.
- W4315620512 cites W2594289944 @default.
- W4315620512 cites W2610373153 @default.
- W4315620512 cites W2757206778 @default.
- W4315620512 cites W2765144383 @default.
- W4315620512 cites W2801088198 @default.
- W4315620512 cites W2899326947 @default.
- W4315620512 cites W2912680111 @default.
- W4315620512 cites W3029741502 @default.
- W4315620512 cites W3037816124 @default.
- W4315620512 cites W3131694754 @default.
- W4315620512 cites W4205802195 @default.
- W4315620512 doi "https://doi.org/10.1080/14756366.2022.2158822" @default.
- W4315620512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36629422" @default.
- W4315620512 hasPublicationYear "2023" @default.
- W4315620512 type Work @default.
- W4315620512 citedByCount "1" @default.
- W4315620512 countsByYear W43156205122023 @default.
- W4315620512 crossrefType "journal-article" @default.
- W4315620512 hasAuthorship W4315620512A5001142695 @default.
- W4315620512 hasAuthorship W4315620512A5004907899 @default.
- W4315620512 hasAuthorship W4315620512A5014679299 @default.
- W4315620512 hasAuthorship W4315620512A5017302012 @default.
- W4315620512 hasAuthorship W4315620512A5024633360 @default.
- W4315620512 hasAuthorship W4315620512A5026614694 @default.
- W4315620512 hasAuthorship W4315620512A5029691584 @default.
- W4315620512 hasAuthorship W4315620512A5031559351 @default.
- W4315620512 hasAuthorship W4315620512A5032152156 @default.
- W4315620512 hasAuthorship W4315620512A5051025265 @default.
- W4315620512 hasAuthorship W4315620512A5069693901 @default.
- W4315620512 hasAuthorship W4315620512A5079455118 @default.
- W4315620512 hasAuthorship W4315620512A5086573420 @default.
- W4315620512 hasAuthorship W4315620512A5086957954 @default.
- W4315620512 hasBestOaLocation W43156205121 @default.
- W4315620512 hasConcept C126322002 @default.